BillionToOne, Inc. (BLLN): Valuation
TTM figures as of June 30, 2026
BillionToOne, Inc. trades at 123.6 times trailing earnings and a 0.71% free-cash-flow yield. The Healthcare median P/E is 22.9.
Earnings yield 0.81%. Shareholder yield 0.00%. ROIC 54.0%. Net cash $457.0M.
10 month-end valuation observations are on file, starting November 2025.
Sector comparison uses 2682 Healthcare names.
Frequently asked questions
Is BLLN cheap versus its own history?
BillionToOne, Inc. trades at 123.6 times trailing earnings and a 0.71% free-cash-flow yield. The Healthcare median P/E is 22.9.
What is BLLN's free-cash-flow yield?
BillionToOne, Inc. currently yields 0.71% of market cap as trailing free cash flow.
Where do these valuation figures come from?
Yields and quality metrics are computed from the same SEC TTM figures as the financials page, against the live market cap. Historical bands reconstruct month-end market cap from split-adjusted closes and the share count in the units it was filed, then divide by those dollar totals. Nothing here is a third-party estimate.